SKI Market

A+| A| A-|

Indian Indices

Sensex

76,899.77 -663.13
( -0.85%)

Global Indices

Nasdaq

47,935.11 1,329.65
(2.85%)

Dow Jones

6,804.45 166.60
(2.51%)

Hang Seng

55,958.99 -349.43
(-0.62%)

Nikkei 225

10,596.41 247.62
(2.39%)

Forex

USD-INR

92.90 -0.03
(-0.03%)

EUR-INR

107.45 0.22
(0.21%)

GBP-INR

123.16 0.23
(0.18%)

JPY-INR

0.58 0.00
(-0.10%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5542386

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

21.44

98210.21

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.32

Back

Welspun Living consolidated net profit declines 99.83% in the December 2025 quarter

Feb 12,2026

Net profit of Welspun Living declined 99.83% to Rs 0.21 crore in the quarter ended December 2025 as against Rs 120.83 crore during the previous quarter ended December 2024. Sales declined 9.13% to Rs 2262.20 crore in the quarter ended December 2025 as against Rs 2489.61 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	2262.20	2489.61	-9
OPM %	7.09	11.26	-
PBDT	135.66	256.61	-47
PBT	33.43	158.38	-79
NP	0.21	120.83	-100

76,899.77 -663.13 ( -0.85%)

47,935.11 1,329.65 (2.85%)

6,804.45 166.60 (2.51%)

55,958.99 -349.43 (-0.62%)

10,596.41 247.62 (2.39%)

92.90 -0.03 (-0.03%)

107.45 0.22 (0.21%)

123.16 0.23 (0.18%)

0.58 0.00 (-0.10%)